Sinopharm Group Co Ltd
HKEX:1099

Watchlist Manager
Sinopharm Group Co Ltd Logo
Sinopharm Group Co Ltd
HKEX:1099
Watchlist
Price: 18.7 HKD Market Closed
Market Cap: 58.4B HKD

Intrinsic Value

The intrinsic value of one Sinopharm Group Co Ltd stock under the Base Case scenario is 81.81 HKD. Compared to the current market price of 18.7 HKD, Sinopharm Group Co Ltd is Undervalued by 77%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
81.81 HKD
Undervaluation 77%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Sinopharm Group Co Ltd

Valuation History Unavailable

Historical valuation for Sinopharm Group Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Sinopharm Group Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Sinopharm Group Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sinopharm Group Co Ltd

Current Assets 347.4B
Cash & Short-Term Investments 54.3B
Receivables 201.5B
Other Current Assets 91.7B
Non-Current Assets 45.4B
Long-Term Investments 11.3B
PP&E 19.6B
Intangibles 8.9B
Other Non-Current Assets 5.5B
Efficiency

Free Cash Flow Analysis
Sinopharm Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sinopharm Group Co Ltd

Revenue
584.5B CNY
Cost of Revenue
-540.3B CNY
Gross Profit
44.3B CNY
Operating Expenses
-26.5B CNY
Operating Income
17.8B CNY
Other Expenses
-10.7B CNY
Net Income
7B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Sinopharm Group Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROE
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
48/100
Profitability
Score

Sinopharm Group Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Sinopharm Group Co Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
56/100
Solvency
Score

Sinopharm Group Co Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Sinopharm Group Co Ltd

Wall Street analysts forecast Sinopharm Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sinopharm Group Co Ltd is 21.98 HKD with a low forecast of 16.67 HKD and a high forecast of 25.94 HKD.

Lowest
Price Target
16.67 HKD
11% Downside
Average
Price Target
21.98 HKD
18% Upside
Highest
Price Target
25.94 HKD
39% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Sinopharm Group Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Sinopharm Group Co Ltd stock?

The intrinsic value of one Sinopharm Group Co Ltd stock under the Base Case scenario is 81.81 HKD.

Is Sinopharm Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 18.7 HKD, Sinopharm Group Co Ltd is Undervalued by 77%.

Back to Top